Suven Life Sciences is contemplating to spend about Rs 60 crore on R&D in FY15. As of 2014 and 2015 the company expects Rs 400-450 crore on the topline and about Rs 80-90 crore on the bottomline.
Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies through the use of GPCR targets.
No comments:
Post a Comment